Tanuxiciclib
Product Specifications
UNSPSC Description
Tanuxiciclib is a cyclin dependent kinase (CDK) inhibitor[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanuxiciclib.html
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N
Molecular Weight
312.30
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145599/Tanuxiciclib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145599/Tanuxiciclib-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1983983-64-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP54761_P050-FITC 100 µL
HIST1H1T Antibody - middle region: FITC (ARP54761_P050-FITC)
Ask
View Details 
MBS629723-01 0.2 mL
NEK2 (Never in Mitosis A-related Kinase 2, NimA-related Protein Kinase 2, NEK2A, HSPK 21, HsPK21, NimA-like Protein Kinase 1, NLK1, Serine/threonine Protein Kinase Nek2)
Ask
View Details MBS629723-02 5x 0.2 mL
NEK2 (Never in Mitosis A-related Kinase 2, NimA-related Protein Kinase 2, NEK2A, HSPK 21, HsPK21, NimA-like Protein Kinase 1, NLK1, Serine/threonine Protein Kinase Nek2)
Ask
View Details 